GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,424.80p
   
  • Change Today:
      11.80p
  • 52 Week High: 2,263.00
  • 52 Week Low: 1,296.00
  • Currency: UK Pounds
  • Shares Issued: 4,094.22m
  • Volume: 1,439,042
  • Market Cap: £58,334m
  • RiskGrade: 129

Latest Deals

Traded Action Notifier PriceAmountValue
17-Jan-23 Buy Dividends Emma Walmsley 1,436.37p 3,591 £51,580.05
12-Jan-23 Buy Dividends Emma Walmsley 1,425.97p 21 £299.45
11-Jan-23 Transfer From Emma Walmsley 0.000p 9 £0.00
11-Jan-23 Buy Emma Walmsley 1,417.19p 9 £127.55

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
17-Jan-23 Buy Dividends Emma Walmsley 1,436.37p 3,591 £51,580.05
12-Jan-23 Buy Dividends Emma Walmsley 1,425.97p 21 £299.45
11-Jan-23 Buy Emma Walmsley 1,417.19p 9 £127.55
11-Jan-23 Transfer From Emma Walmsley 0.000p 9 £0.00

Director Shareholdings

Notifier Holding Value*
Emma Walmsley 2,516,702 £35,857,970
Hal Barron 345,920 £4,928,668
Jonathan Symonds 35,743 £509,266
Charles Bancroft 13,261 £188,943
Jesse Goodman 9,525 £135,712
Urs Rohner 9,404 £133,988
Iain Mackay 7,682 £109,453
Vishal Sikka 2,294 £32,685
Anne Beal 1,519 £21,643
Harry (Hal) C. Dietz 1,486 £21,172

Major Shareholders

Notifier** Holding Value*
Dodge & Cox 253,464,108 £3,611,356,611
BlackRock Inc 229,134,683 £3,264,710,963
Dodge & Cox 162,217,029 £2,311,268,229
The Capital Group Companies, Inc. 159,068,073 £2,266,401,904
Legal & General Group Plc 95,878,187 £1,366,072,408

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,424.80p
Change Today 11.80p
% Change 0.84 %
52 Week High 2,263.00
52 Week Low 1,296.00
Volume 1,439,042
Shares Issued 4,094.22m
Market Cap £58,334m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
83.48% above the market average83.48% above the market average83.48% above the market average83.48% above the market average83.48% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
52.76% below the market average52.76% below the market average52.76% below the market average52.76% below the market average52.76% below the market average
24.59% above the sector average24.59% above the sector average24.59% above the sector average24.59% above the sector average24.59% above the sector average
Income
66.67% above the market average66.67% above the market average66.67% above the market average66.67% above the market average66.67% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
78.44% below the market average78.44% below the market average78.44% below the market average78.44% below the market average78.44% below the market average
94.87% below the sector average94.87% below the sector average94.87% below the sector average94.87% below the sector average94.87% below the sector average

What The Brokers Say

Strong Buy 2
Buy 6
Neutral 15
Sell 1
Strong Sell 1
Total 25
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q3 Q2
Ex-Div 17-Nov-22 18-Aug-22
Paid 12-Jan-23 06-Oct-22
Amount 13.75p 16.25p

Trades for 31-Jan-2023

Time Volume / Share Price
13:34 211 @ 1,424.80p
13:34 397 @ 1,424.60p
13:34 24 @ 1,424.20p
13:33 57 @ 1,424.20p
13:33 966 @ 1,424.40p

GSK Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page